FDAnews Device Daily Bulletin

J&J AND GUIDANT: BUYER BEWARE

Nov. 17, 2005
A A

The Nov. 15 news that Johnson & Johnson and Guidant had agreed on a new deal came as a bit of a surprise to investors. Guidant, which had sued J&J to complete the transaction under the original terms, saw its stock climb more than 8% after agreeing to a $21.5 billion buyout, about $4 billion less than originally planned.

Business Week (http://www.businessweek.com/technology/content/nov2005/tc20051116_925095.htm)